Latest News

Please wait while we gather your results.

Job Research Foundation Announces 5th Round of Funding

The Job Research Foundation, which seeks to help find a cure for Job Syndrome by providing the global scientific community with additional opportunities to further research into the rare multisystem immunodeficiency disorder, has announced the fifth round of grant funding.

Learn More

Use Of A Response-Adapted Ruxolitinib-Containing Regimen For The Treatment Of Hemophagocytic Lymphohistiocytosis

In collaboration with the North American Consortium for Histiocytosis (NACHO), Melissa Hines and Kim Nichols are running a clinical trial investigating the efficacy and tolerability of a response-adapted ruxolitinib-containing regimen for children with newly diagnosed or relapsed/refractory HLH. The protocol is now open at 10 participating sites.

Learn More

ABAI, AAAAI, ACAAI, CIS Joint Statement on the Impact of the U.S. Supreme Court Dobbs v. Jackson

Read the joint statement from ABAI, AAAAI, ACAAAI and CIS regarding the Supreme Court decision on Dobbs v Jackson.

Learn More

CIS Statement on Supreme Court Decision

Read the statement from the CIS Executive Council regarding the latest Supreme Court decision on Dobbs v Jackson.

Learn More

The 2022 Michelson Prizes: Next Generation Grants

The Michelson Medical Research Foundation (MMRF), together with the Human Vaccines Project, established the Michelson Prizes: Next Generation Grants in 2017. This $20 million initiative supports research proposals from young investigators who are using disruptive research concepts and inventive processes to significantly advance the development of vaccines and immunotherapies for major global diseases.

Learn More